C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/06 (2006.01) A61K 31/445 (2006.01) A61P 3/00 (2006.01) C07D 211/56 (2006.01) C07D 401/14 (2006.01) C07D 491/10 (2006.01) C07D 491/20 (2006.01)
Patent
CA 2621255
The present invention relates to inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-.beta. hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
L'invention concerne des inhibiteurs de la 11-ß hydroxyl steroïde déshydrogénase de type 1, des antagonistes du récepteur de minéralocorticoïde (MR), et des compositions pharmaceutiques contenant ces composés. Les composés de l'invention conviennent pour le traitement de diverses pathologies associées à l'expression ou à l'activité de 11-ß hydroxyl stéroide déshydrogénase de type 1 et ou de maladies associées à un excès d'aldostérone.
Qian Ding-Quan
Yao Wenqing
Zhuo Jincong
Incyte Corporation
Smart & Biggar
LandOfFree
Amido compounds and their use as pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amido compounds and their use as pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amido compounds and their use as pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2027256